Beirut, Lebanon Clinical Trials

A listing of Beirut, Lebanon clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 81 clinical trials
Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa

The purpose of this study is to evaluate the effect of L-Dopa on the progression of retinitis pigmentosa.

levodopa
Beirut Eye Specialist Hospital
 (0.5 away) Contact site
  • 459 views
  • 21 Jan, 2021
  • 1 location
Evaluation of Efficacy and Safety of Pamrevlumab in Patients With Idiopathic Pulmonary Fibrosis

This is a Phase 3 trial to evaluate the efficacy and safety of 30 mg/kg intravenous (IV) infusions of pamrevlumab administered every 3 weeks as compared to placebo in subjects with Idiopathic Pulmonary Fibrosis

pamrevlumab
carbon monoxide
idiopathic pulmonary fibrosis
diffusion capacity of the lung for carbon monoxide
nintedanib
Gaspare Rodiloco Hospital
 (1167.1 away) Contact site
  • 349 views
  • 10 Jun, 2021
  • +164 other locations
Switch to Oral Antibiotics in Gram-negative Bacteremia

Eligible subjects will be those age 18 years or more with mono-microbial blood stream infection caused by E. coli, Klebsiella species, Enterobacter species, Serratia species, Citrobacter species, or Proteus species, who have achieved adequate source control, are afebrile and hemodynamically stable for 48 hours or more and have received microbiologically …

Ordu University School of Medicine
 (505.1 away) Contact site
  • 73 views
  • 10 Feb, 2021
  • +8 other locations
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

The purpose of this open-label extension (OLE) study is to evaluate the safety and efficacy of etrasimod in participants with moderately to severely active ulcerative colitis (UC) who previously received double-blinded treatment (either etrasimod 2 mg per day or placebo) during participation in one of two Phase 3 double-blinded, placebo-controlled …

Galilee Medical Center
 (65.2 away) Contact site
  • 133 views
  • 07 Jun, 2021
  • +364 other locations
HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

This study will evaluate the efficacy and safety of vutrisiran 25 mg administered subcutaneously (SC) once every 3 months (q3M) compared to placebo in patients with ATTR amyloidosis with cardiomyopathy.

Clinical Trial Site
 (81.2 away) Contact site
  • 32 views
  • 28 May, 2021
  • +91 other locations
A Study to Evaluate Long-term Safety in Subjects Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

A Phase 3b, open-label, single-arm, rollover study to evaluate the long-term safety of luspatercept, to the following subjects: Subjects receiving luspatercept on a parent protocol at the time of their transition to the rollover study, who tolerate the protocol-prescribed regimen in the parent trial and, in the opinion of the …

cancer
growth factor
hysterectomy
ace-536
luspatercept
Chronic Care Center
 (3.3 away) Contact site
  • 82 views
  • 27 Jan, 2021
  • +124 other locations
CLCZ696B2319E1 OL Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HF

The purpose of this study is to evaluate long-term safety and tolerability data in eligible CLCZ696B2319 (PANORAMA-HF) patients receiving open-label sacubitril/valsartan.

valsartan
Novartis Investigative Site
 (1.1 away) Contact site
  • 5 views
  • 16 May, 2021
  • +65 other locations
Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)

The purpose of this study is to demonstrate superiority of secukinumab at Week 16, based on Hidradenitis Suppurativa Clinical Response (HiSCR) rates versus placebo, along with the maintenance of efficacy of secukinumab at Week 52 in subjects with moderate to severe HS. Moreover, this study will also assess the safety …

hidradenitis
secukinumab
antiseptics
abscess
Novartis Investigative Site
 (3.3 away) Contact site
  • 909 views
  • 14 Jun, 2021
  • +112 other locations
A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

This is a Phase 2/3 study that comprises 5 substudies designed to evaluate the efficacy, safety, and tolerability of oral etrasimod as therapy in adult participants with moderately to severely active Crohn's disease (CD) who are refractory or intolerant to at least 1 of the current therapies for CD (ie, …

adalimumab
ustekinumab
methotrexate
tumor necrosis factor
vedolizumab
Saint George University Hospital Medical Center
 (0.5 away) Contact site
  • 63 views
  • 15 May, 2021
  • +122 other locations
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

The purpose of this study is to evaluate the safety and tolerability of long-term treatment with ontamalimab in participants with moderate to severe Ulcerative Colitis (UC) or Crohn's disease (CD).

sigmoidoscopy or colonoscopy
crohn's disease
colitis
flexible sigmoidoscopy
vedolizumab
Hammoud Hospital University Medical Center
 (24.3 away) Contact site
  • 1349 views
  • 15 Jun, 2021
  • +824 other locations